Today: 25 January 2026
Subscribe

Marcin Frąckiewicz

CEO of TS2 Space and founder of TS2.tech. Expert in satellites, telecommunications, and emerging technologies, covering trends in space, AI, and connectivity.

Quantum Leap: SEALSQ Corp (LAES) Rockets on Post-Quantum Breakthroughs and Bold Global Moves

Quantum Leap: SEALSQ Corp (LAES) Rockets on Post-Quantum Breakthroughs and Bold Global Moves

Detailed Analysis Rally Fueled by Post-Quantum Breakthroughs SEALSQ Corp’s stock (NASDAQ: LAES) has been on a tear in early October 2025, coinciding with major post-quantum technology announcements. The share price climbed for four sessions straight, culminating in a +7.7% jump on Oct 4alone and a 27% cumulative gain over that week Ainvest. This surge propelled LAES to its highest levels since its listing, with…
10 October 2025
····
APLD Stock Skyrockets on AI Deals: Applied Digital’s Big 2025 Rally, Earnings Blowout & What’s Next

APLD Stock Skyrockets on AI Deals: Applied Digital’s Big 2025 Rally, Earnings Blowout & What’s Next

Stock Price Surge and Recent Performance Applied Digital’s stock has delivered eye-popping returns in 2025, emerging as one of the market’s hottest tech plays. Year-to-date, APLD shares have climbed roughly +280% 247Wallst, reflecting investors’ enthusiasm for companies tied to the AI infrastructure boom. The rally intensified in late September and early October: between Sept 30 and Oct 2 alone, APLD stock jumped about 19% (from ~$22…
10 October 2025
····
Levi Strauss Shocks Wall Street: Denim Demand Soars, Forecast Raised – Why LEVI Stock Still Slipped

Levi Strauss Shocks Wall Street: Denim Demand Soars, Forecast Raised – Why LEVI Stock Still Slipped

Blockbuster Q3 Earnings – Sales Beat and Outlook Raised Levi Strauss & Co. delivered strong third-quarter 2025 results, topping estimates and defying retail sector headwinds. Revenue for Q3 (June–August 2025) hit $1.54 billion, up 7% year-on-year and slightly above analyst expectations of ~$1.50 billion Reuters Tipranks. Adjusted earnings were $0.34 per share, a penny higher than a year ago and beating the $0.31 consensus estimate Tipranks. The company achieved broad-based growth across…
10 October 2025
··
New Era Energy & Digital (NUAI) Stock Skyrockets on AI Data Center Dreams – Key Updates & Outlook

New Era Energy & Digital (NUAI) Stock Skyrockets on AI Data Center Dreams – Key Updates & Outlook

Latest Developments & October Stock Surge After a quiet summer, New Era Energy & Digital’s stock exploded in early October 2025 on the back of major project news and aggressive investor outreach. On October 9, NUAI shares nearly doubled intraday – a one-day jump of roughly 80% – following fresh updates on its West Texas data center venture Investing. The rally took the stock…
9 October 2025
····
Costco Stock Surges Amid Retail Gloom – Will $900+ Shares Keep Climbing?

Costco Stock Soars Amid Retail Gloom – What’s Driving the Rally and Will It Last?

Stock Price & Recent Performance Costco’s stock has been on a long-term upward climb, and 2025 is no exception – though it hasn’t been a smooth ride. After a strong rally in the first half of the year, Costco (COST) shares reached an intraday record high around $1,078earlier in 2025 ts2.tech. Enthusiasm was fueled by robust sales growth and a broader…
9 October 2025
····
USA Rare Earth Stock Skyrockets on Rare Earth Boom and White House Buzz – What’s Driving USAR’s Record High?

USA Rare Earth (USAR) Stock Soars on Rare Earth Boom and White House Buzz – What Investors Need to Know

Company Background & Operations USA Rare Earth, Inc. is a U.S.-based critical minerals company focused on establishing a fully domestic rare-earth supply chain – from mining and processing raw rare earth elements to manufacturing finished rare-earth magnets. The company’s flagship asset is the Round Top Mountain rare-earth deposit in Texas, which contains a broad range of critical rare earth elements (including heavy REEs like dysprosium and…
9 October 2025
···
Akero Therapeutics (AKRO) Skyrockets on $5.2 B Novo Nordisk Buyout – Pipeline Breakthroughs & Expert Outlook

Akero Therapeutics (AKRO) Skyrockets on $5.2 B Novo Nordisk Buyout – Pipeline Breakthroughs & Expert Outlook

Sources: Akero Therapeutics investor materials; Novo Nordisk press statements; Reuters, TS2.tech and FierceBiotechnews reports ts2.tech ts2.tech Fiercebiotech; MarketBeat and DirectorsTalk analyst surveys Marketbeat Directorstalkinterviews; Economic Times deal summary Indiatimes Indiatimes; Business Wire legal alert Businesswire Businesswire; and TradingView market data Marketbeat Tradingview.…
9 October 2025
····
Turn Therapeutics (TTRX) Skyrockets After Nasdaq Debut – Biotech Breakthrough or Hype?

Turn Therapeutics (TTRX) Skyrockets After Nasdaq Debut – Biotech Breakthrough or Hype?

Company Profile – Background & Leadership Turn Therapeutics, Inc. is a Westlake Village, CA-based biotech company founded in 2015 Renaissancecapital. The company (formerly named Global Health Solutions, Inc.) officially rebranded to Turn Therapeutics in Sept 2025 ahead of its Nasdaq listing Stockanalysis. Turn’s mission is to “turn the tides” in medicine by developing technologies that heal, not just manage, challenging traditional treatments Benzinga. CEO Bradley…
9 October 2025
····
Novo Nordisk’s $5.2 Billion Bet to Reverse Fatty Liver Disease – Game-Changer or Big Gamble?

Novo Nordisk’s $5.2 Billion Bet to Reverse Fatty Liver Disease – Game-Changer or Big Gamble?

Forecast: Experts believe that within the next 2–3 years, we’ll know if Novo’s gamble pays off. Phase 3 readouts for efruxifermin are anticipated in 2026, and Novo hopes to launch the drug by late this decade if approved Reuters. By then, the landscape may include other new NASH therapies (possibly Lilly’s or Madrigal’s), but Novo’s combination strategy could set it apart. Wolfe Research…
9 October 2025
·
PepsiCo (PEP) Stock: Q3 Earnings Surprise, “Ozempic Effect” Fears & Activist Investor Shake-Up – What’s Next?

PepsiCo (PEP) Stock: Q3 Earnings Surprise, “Ozempic Effect” Fears & Activist Investor Shake-Up – What’s Next?

Key Data & Metrics (as of October 9, 2025) Metric Value Stock Price (Oct 8, 2025) $138.84 (close) MarketbeatDown ~6% in past month; ~–6% YTD Finviz Indexbox 52-Week Range Low $127.60 – High $177.48 Businessinsider Market Capitalization ~$193 Billion Businessinsider Forward P/E (2025E) ~17.5× (near industry avg ~17.5×) Finviz Trailing P/E (TTM) ~21.8× Businessinsider PEG Ratio (Forward) ~3.5 (industry ~2.3)…
9 October 2025
····
Delta Air Lines Stock Takes Off on Strong Earnings and Upbeat Outlook

Delta Air Lines Stock Takes Off on Strong Earnings and Upbeat Outlook

Stock Performance and Recent Price Action Delta’s stock has been on the move following its latest earnings. As of October 9, 2025, DAL trades around $60 per share after spiking about 5–6% on the Q3 report Tradingview. This marks a sharp rebound from the mid-$50s levels seen earlier in the week. Over the past week, the stock ranged roughly $56–$58 and is now up slightly week-over-week,…
9 October 2025
····
Double Meteor Shower Spectacle: Draconid and Orionid Displays Will Light Up October’s Night Sky

Meteor Storm or Moonlit Fizzle? Draconid ‘Dragon’ Meteor Shower Peaks Tonight with Skywatchers on Alert

The Draconids: A “Dragon” in the Night Sky Every October, the Draconid meteor shower gives skywatchers a chance – however slim – to see fireballs from the Dragon. The Draconids occur when Earth passes through dust debris shed by Comet 21P/Giacobini–Zinner, a small periodic comet that orbits the sun every 6.6 years ts2.tech. As these cometary bits hit Earth’s atmosphere at a relatively languid…
9 October 2025
···
1 … 396 397 398 399 400 … 584

Stock Market Today

  • PAL GROUP Holdings Boosts Year-End Dividend to ¥40, Enhancing Shareholder Value
    January 25, 2026, 9:48 AM EST. PAL GROUP Holdings (TSE:2726) announced a 33% increase in its year-end dividend to ¥40 per share, effective May 27, 2026, reflecting stronger sales and profits for the nine months ended November 2025. The move aims to reinforce the company's commitment to stable, profit-linked shareholder returns amid ongoing governance changes, including adjustments to directors and auditors post board meeting. While the dividend hike partially offsets recent share price weakness, key challenges remain, such as maintaining margins and managing leadership transition. Market analysts highlight a nuanced risk-reward balance, with fair value estimates ranging near ¥2,500, suggesting the stock may still be undervalued by 32% despite governance concerns. Investors are advised to monitor capital allocation and board independence as the company navigates these changes.
Go toTop